Onychomycosis Market
Onychomycosis Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Onychomycosis Market Size and Growth
The Onychomycosis market is experiencing significant growth, driven by increasing prevalence and awareness of fungal infections. The market size was valued at approximately $6.4 billion in 2022 and is projected to reach around $9.1 billion by 2030, fueled by advancements in treatment options and rising healthcare expenditures.
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Glaxosmithkline
◍ Pfizer
◍ Bausch Health
◍ Galderma
◍ Janssen Biotech
◍ Bristol Meyer Squibb
◍ Topica Pharmaceuticals
◍ Sanofi
◍ Novartis
The Onychomycosis market features major players like Abbott Laboratories, GlaxoSmithKline, and Pfizer, offering antifungal treatments that drive growth. Companies utilize innovative therapies, increase market access, and enhance patient outcomes. Notable revenues include Pfizer’s $51.8 billion and Galderma’s estimated $2.3 billion, supporting continued investment in onychomycosis solutions. Request Sample Report
Market Segmentation
By Application
◍ Retail Pharmacies
◍ Others
By Product
Others ◍ Hospital Pharmacies
◍ Distal Subungual Onychomycosis
◍ White Superficial Onychomycosis
◍ Proximal Subungual Onychomycosis ◍ Candida Onychomycosis
$ 11.50 Billion
Request Sample Report
